177
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Preparation, characterization, and evaluation of amino acid modified magnetic nanoparticles: drug delivery and MRI contrast agent applications

ORCID Icon, , , , & ORCID Icon
Pages 1156-1167 | Received 29 Jan 2018, Accepted 20 Sep 2018, Published online: 09 Nov 2018

References

  • Anand KV, Mohamed Jaabir MS, Thomas PA, Geraldine P. 2012. Protective role of chrysin against oxidative stress in d‐galactose‐induced aging in an experimental rat model. Geriatr Gerontol Int. 12:741–750.
  • Arami H, Khandhar A, Liggitt D, Krishnan KM. 2015. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev. 44:8576–8607.
  • Babu KS, Babu TH, Srinivas P, Kishore KH, Murthy U, Rao JM. 2006. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents. Bioorg Med Chem Lett. 16:221–224.
  • Chen SS, Corteling R, Stevanato L, Sinden J. 2012. Polyphenols inhibit indoleamine 3, 5-dioxygenase-1 enzymatic activity—a role of immunomodulation in chemoprevention. Discov Med. 14:327–333.
  • Cristescu R, Visan A, Socol G, Surdu AV, Oprea AE, Grumezescu AM, Chifiriuc MC, Boehm RD, Yamaleyeva D, Taylor M, et al. 2016. Antimicrobial activity of biopolymeric thin films containing flavonoid natural compounds and silver nanoparticles fabricated by MAPLE: a comparative study. Appl Surf Sci. 374:290–296.
  • Durmus Z, Kavas H, Toprak MS, Baykal A, Altınçekiç TG, Aslan A, Bozkurt A, Coşgun S. 2009. L-lysine coated iron oxide nanoparticles: synthesis, structural and conductivity characterization. J Alloys Compd. 484:371–376.
  • García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA. 2009. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 58:537–552.
  • Javid A, Ahmadian S, Saboury AA, Kalantar SM, Rezaei‐Zarchi S. 2013. Chitosan‐coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells. Chem Biol Drug Des. 82:296–306.
  • Khan R, Khan AQ, Qamar W, Lateef A, Tahir M, Rehman MU, Ali F, Sultana S. 2012. Chrysin protects against cisplatin-induced colon toxicity via amelioration of oxidative stress and apoptosis: probable role of p38MAPK and p53. Toxicol Appl Pharmacol. 258:315–329.
  • Lefnaoui S, Moulai-Mostefa N. 2015. Polyelectrolyte complex based on carboxymethyl-kappa-carrageenan and Eudragit RL 30D as prospective carriers for sustained drug delivery. Chem Eng Res Des. 97:165–174.
  • Lince F, Bolognesi S, Stella B, Marchisio DL, Dosio F. 2011. Preparation of polymer nanoparticles loaded with doxorubicin for controlled drug delivery. Chem Eng Res Des. 89:2410–2419.
  • Mahmoudi M, Serpooshan V, Laurent S. 2011. Engineered nanoparticles for biomolecular imaging. Nanoscale. 3:3007–3026.
  • Martín M, Salazar P, Villalonga R, Campuzano S, Pingarrón JM, González-Mora JL. 2014. Preparation of core–shell Fe3O4@ poly (dopamine) magnetic nanoparticles for biosensor construction. J Mater Chem B. 2:739–746.
  • Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46:6387–6392.
  • Mirmasoumi M, Azadi P, Sharafi A, Ntui Otang V, Mii M. 2013. Simple protocol for plant regeneration of Lilium ledebourii using transverse thin cell layer. Prog Biol Sci. 3:117–122.
  • Mirzaee H, Sharafi A, Sohi HH. 2016. In vitro regeneration and transient expression of recombinant sesquiterpene cyclase (SQC) in Artemisia annua L. S Afr J Bot. 104:225–231.
  • Nosrati H, Adibtabar M, Sharafi A, Danafar H, Hamidreza Kheiri M. 2018a. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells. Drug Dev Ind Pharm. 44(8):1377–1384.
  • Nosrati H, Hamzehei H, Afroogh S, Ashabi SF, Attari E, Manjili HK. 2018b. Phenyl alanine & tyrosine amino acids coated magnetic nanoparticles: preparation and toxicity study. Drug Res. DOI: 10.1055/a-0664-0431.
  • Nosrati H, Salehiabar M, Attari E, Davaran S, Danafar H, Manjili HK. 2017. Green and one‐pot surface coating of iron oxide magnetic nanoparticles with natural amino acids and biocompatibility investigation. Appl Organometal Chem. 32:e4069.
  • Pan Y, Du X, Zhao F, Xu B. 2012. Magnetic nanoparticles for the manipulation of proteins and cells. Chem Soc Rev. 41:2912–2942.
  • Park JY, Choi ES, Baek MJ, Lee GH. 2009. Colloidal stability of amino acid coated magnetite nanoparticles in physiological fluid. Mater Lett. 63:379–381.
  • Pušnik K, Peterlin M, Kralj-Cigic I, Marolt G, Kogej K, Mertelj A, Gyergyek S, Makovec D. 2016. Adsorption of amino acids, aspartic acid and lysine onto iron-oxide nanoparticles. J Phys Chem C. 120:14372–14381.
  • Qu H, Ma H, Zhou W, O’Connor CJ. 2012. In situ surface functionalization of magnetic nanoparticles with hydrophilic natural amino acids. Inorg Chim Acta. 389:60–65.
  • Schwaminger SP, García PF, Merck GK, Bodensteiner FA, Heissler S, Günther S, Berensmeier S. 2015. Nature of interactions of amino acids with bare magnetite nanoparticles. J Phys Chem C. 119:23032–23041.
  • Shaabani A, Nosrati H, Hezarkhani Z, Afshari R, 2018. One-pot oxidative Groebke–Blackburn–Bienayme reaction of alcohols: using bio-supported and magnetically recyclable Fe2O3@ cellulose and Fe2O3@ cellulose–SO3H nanocomposites for the synthesis of 3-aminoimidazo [1, 2-a] pyridines. Monatshefte Chem-Chem Monthly. 149(8):1459–1467.
  • Shaabani A, Nosrati H, Seyyedhamzeh M. 2015. Cellulose@ Fe2O3 nanoparticle composites: magnetically recyclable nanocatalyst for the synthesis of 3-aminoimidazo [1, 2-a] pyridines. Res Chem Intermed. 41:3719–3727.
  • Sousa M, Rubim J, Sobrinho P, Tourinho F. 2001. Biocompatible magnetic fluid precursors based on aspartic and glutamic acid modified maghemite nanostructures. J Magn Magn Mater. 225:67–72.
  • Sultana S, Verma K, Khan R. 2012. Nephroprotective efficacy of chrysin against cisplatin‐induced toxicity via attenuation of oxidative stress. J Pharm Pharmacol. 64:872–881.
  • Tahir M, Sultana S. 2011. Chrysin modulates ethanol metabolism in Wistar rats: a promising role against organ toxicities. Alcohol Alcohol. 46:383–392.
  • Tarantash M, Nosrati H, Kheiri Manjili H, Baradar Khoshfetrat A. 2018. Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles. Drug Dev Ind Pharm. 44:1895–1903.
  • Ursin G, Longnecker MP, Haik RW, Greenland S. 1995. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 6:137–141.
  • Vatten LJ, Kvinnsland S. 1992. Prospective study of height, body mass index and risk of breast cancer. Acta Oncol. 31:195–200.
  • Xie J, Wang J, Niu G, Huang J, Chen K, Li X, Chen X. 2010. Human serum albumin coated iron oxide nanoparticles for efficient cell labeling. Chem Commun. 46:433–435.
  • Yallapu MM, Othman SF, Curtis ET, Bauer NA, Chauhan N, Kumar D, Jaggi M, Chauhan SC. 2012. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 7:1761.
  • Zhang K, Guan X, Qiu Y, Wang D, Zhang X, Zhang H. 2016. A pH/glutathione double responsive drug delivery system using molecular imprint technique for drug loading. Appl Surf Sci. 389:1208–1213.
  • Zheng H, Li S, Pu Y, Lai Y, He B, Gu Z. 2014. Nanoparticles generated by PEG-Chrysin conjugates for efficient anticancer drug delivery. Eur J Pharm Biopharm. 87:454–460.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.